Literature DB >> 11869329

Primary malignant melanoma of the esophagus treated by esophagectomy and systemic chemotherapy.

T Matsutani1, M Onda, M Miyashita, N Hagiwara, Y Akiya, K Takubo, K Yamashita, K Sasajima.   

Abstract

We describe herein a case of asymptomatic primary malignant melanoma of the esophagus. A 65-year-old man presented with a 4-cm filling defect in the middle third of the esophagus on a routine barium swallow. Subtotal esophagectomy accompanied by lymph node dissection was performed through a right thoracotomy. Postoperatively, the patient received five cycles of systemic chemotherapy with dacarbazine (DTIC), nimustine hydrochloride (ACNU), and vincristine (VCR) (DAV therapy), but ultimately died of generalized metastatic disease 15 months after surgery. Malignant melanoma of the esophagus has an extremely poor prognosis despite various therapeutic efforts.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11869329     DOI: 10.1046/j.1442-2050.2001.00193.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  6 in total

1.  Multimodality management of a locally advanced primary oesophageal melanoma with radical surgery and adjuvant chemoimmunoradiotherapy.

Authors:  R Díaz; P Moral; M Fonfría; M de Juan; N Mancheño; A Tormo
Journal:  Clin Transl Oncol       Date:  2010-04       Impact factor: 3.405

2.  Unusual clinical course of metachronous melanomas of the upper digestive system.

Authors:  Andrzej Dabrowski; Krzysztof Zinkiewicz; Justyna Szumilo; Witold Zgodzinski; Grzegorz Cwik; Tomasz Skoczylas; Grzegorz Wallner
Journal:  World J Gastroenterol       Date:  2005-04-14       Impact factor: 5.742

3.  Synchronous primary oesophageal malignant melanoma and sigmoid adenocarcinoma.

Authors:  Ahsan Malik; Sandeep Bansil; Naushad Junglee; Jonathon Sutton; Jaber Gasem; Waqar Ahmed
Journal:  BMJ Case Rep       Date:  2011-07-28

4.  Surgical treatment of primary malignant melanoma of the esophagus: a case report.

Authors:  Song Am Lee; Jae Joon Hwang; Young Ho Choi
Journal:  J Korean Med Sci       Date:  2007-02       Impact factor: 2.153

5.  miR-498 Targets UBE2T to Inhibit the Proliferation of Malignant Melanoma Cells.

Authors:  Wen Cao; Li Ni; Pin Li; Qi-Xia Wang; Ming-Ming Li; Shu-Hong Huang; Ning-Ning Dang
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

Review 6.  The Thousand Faces of Malignant Melanoma: A Systematic Review of the Primary Malignant Melanoma of the Esophagus.

Authors:  Gerardo Cazzato; Eliano Cascardi; Anna Colagrande; Teresa Lettini; Leonardo Resta; Cinzia Bizzoca; Francesca Arezzo; Vera Loizzi; Miriam Dellino; Gennaro Cormio; Nadia Casatta; Carmelo Lupo; Antonio Scillimati; Salvatore Scacco; Paola Parente; Lucia Lospalluti; Giuseppe Ingravallo
Journal:  Cancers (Basel)       Date:  2022-07-30       Impact factor: 6.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.